IDO Updates At ASCO: Incyte's Combos With Merck And Bristol Take Center Stage

The immuno-oncology highlight of the upcoming American Society of Clinical Oncology annual meeting will be clinical data for Incyte's epacadostat with Merck's Keytruda as well as data with Bristol's Opdivo.